Shareholding disclosure

Prinz Michael von und zu Liechtenstein

Declared position

57.5%

Threshold

Crossed upwards

Timeline

Published

27.09.2011

Transaction

20.09.2011

Voting rights breakdown

Voting rights acquired57.5%

Voting rights sold0%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

TBB9N00061

Beneficial owner

Prinz Michael von und zu Liechtenstein

Declared address

Prinz Michael von und zu Liechtenstein, 9490 Vaduz

Mondobiotech Holding AG's extraordinary general shareholders' meeting on 14/09/2011 has approved the creation of a single share type. As a consequence, the unchanged share capital of Mondobiotech Holding AG consists now of no. 68'917'580 registered shares with a par value of CHF 0.01 each. Because of this, the participation of this Group has fallen below the 66 2/3% treshold. The Stiftung PMSERV owns 95.54% of the share capital of BIOPHARMAinvest AG. The remaining 4.46% is held by former Board members and Executive Committee members of Mondobiotech Holding AG.Due to the small amount of such minority participation, all Mondobiotech Holding AG's shares held by BIOPHARMAinvest are attributed to this Group.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Prinz Michael von und zu Liechtenstein

MindMaze Therapeutics Holding SA27.09.2011TBB9N00061

Disclosure summary

Prinz Michael von und zu Liechtenstein disclosed a holding in MindMaze Therapeutics Holding SA on the acquisition side, published by SIX Exchange Regulation on 27.09.2011, at 57.5% of voting rights. Notice category: Group of shareholders.

Disclosed position

57.5%

Voting rights acquired

Voting rights acquired57.5%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Prinz Michael von und zu Liechtenstein disclosed a holding in MindMaze Therapeutics Holding SA, published on 27.09.2011.

Publication date27.09.2011

Transaction date20.09.2011

Issuing companyMindMaze Therapeutics Holding SA

Beneficial ownerPrinz Michael von und zu Liechtenstein

Declared addressPrinz Michael von und zu Liechtenstein, 9490 Vaduz

CategoryGroup of shareholders

Voting rights acquired57.5%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTBB9N00061

Conditions

Mondobiotech Holding AG's extraordinary general shareholders' meeting on 14/09/2011 has approved the creation of a single share type. As a consequence, the unchanged share capital of Mondobiotech Holding AG consists now of no. 68'917'580 registered shares with a par value of CHF 0.01 each. Because of this, the participation of this Group has fallen below the 66 2/3% treshold. The Stiftung PMSERV owns 95.54% of the share capital of BIOPHARMAinvest AG. The remaining 4.46% is held by former Board members and Executive Committee members of Mondobiotech Holding AG.Due to the small amount of such minority participation, all Mondobiotech Holding AG's shares held by BIOPHARMAinvest are attributed to this Group.

Source: SIX Exchange Regulation · Publication date: 27.09.2011

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open